Development of epilepsy after recovery from posterior reversible encephalopathy syndrome in children with renal disease

Masaki Takahashi(Tokyo Metropolitan Bokutoh Hospital), Shuichi Ito(National Center For Child Health and Development), Kenji Ishikura(Kitasato University), Koichi Kamei(National Center For Child Health and Development), Yuichi Abe(National Center For Child Health and Development), Masao Ogura(Hokkaido University Hospital), Mai Sato(Kyoto University), Itaru Hayakawa(National Center For Child Health and Development)
Medicine Case Reports and Study Protocols
October 1, 2022
10.1097/md9.0000000000000236
Cited by 1

Related Papers

Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial
|The Lancet|2014|450
IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome
|Pediatric Nephrology|2022|278
Creatinine-based equation to estimate the glomerular filtration rate in Japanese children and adolescents with chronic kidney disease
|Clinical and Experimental Nephrology|2013|267
Epidemiology of pediatric chronic kidney disease/kidney failure: learning from registries and cohort studies
|Pediatric Nephrology|2021|149
A multicenter randomized trial indicates initial prednisolone treatment for childhood nephrotic syndrome for two months is not inferior to six-month treatment
|Kidney International|2014|135